Ivermectin Tested against 28 types of Cancer: Most Sensitive vs Least Sensitive

A research group from Mexico investigated Ivermectin in Cancer. This is the first study that has tested as many as 28 Cancer types with Ivermectin. 


Paper: 2020 (Juarez et al) - Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug. 

Ivermectin was tested at 2mg/kg/day which translates to roughly 5uM in vitro concentration.

The most sensitive cancer cell lines were: 1. Ovarian 2. Breast 3. Glioblastoma 4. Lung Cancer 5. Colon Cancer 6. Uterine SCC 7. hepatocellular 8. breast TNBC 9. Pancreatic 10. Endometrial 

Least sensitive were: 1. osteosarcoma 2. gastric 3. melanoma 

Although lymphoma and leukemia cell lines appear to be more resistant to Ivermectin, Ivermectin has a significant impact on those cells' ability to form colonies. So yes, Ivermectin is useful against BOTH lymphomas and leukemias. 

Ivermectin also goes after CANCER STEM CELLS, which tend to be resistant to chemotherapy:
 
“Ivermectin has a preferential depletion effect on the cancer stem-like cell population…” 

“We observed that among all the evaluated cell lines, a decrease in cell viability and clonogenicity is more evident in the cancer stem-like cells than in their parental population.” 

KEY findings of this study: At a human dose of 2mg/kg, Ivermectin can achieve anti-cancer effects such as cell cycle arrest (inhibit proliferation), preferrential inhibition of cancer stem-like cells, synergize with several chemotherapy drugs and inhibit tumor growth in a breast cancer mouse model. 


Comments

Labels

Show more

Archive

Show more

Popular posts from this blog

Ivermectin and Fenbendazole: Treating Turbo Cancer - Dr William Makis

Fenbendazole Joe Tippens Protocol: A Step-by-Step Guide (2024)

Fenbendazole Cancer Success Stories: 107 Case Reports Compilation (February 2025 Edition)

Ivermectin, Fenbendazole and Mebendazole in Cancer: 2024 Peer-Reviewed Protocol in Cancer

Fenbendazole: Side Effects, Safety and Dosage in Humans (2025)

Fenbendazole: Questions Answered, Things to Know, Useful Tips - Ben Fen

FENBENDAZOLE and CANCER: 15 Minutes with Dr. William Makis

Exploring the Anticancer Potential of Fenbendazole: A Review of Anecdotal Case Reports and Emerging Evidence (2025)

Fenbendazole vs Mebendazole for Cancer: What is the Difference?

Fenbendazole for Humans: Safety and Efficacy Examined (2025)